Melatonin and cancer

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Melatonin is a hormone primarily known for regulating sleep-wake cycles.
• Emerging evidence indicates melatonin's involvement in cellular processes beyond circadian rhythm.
• Its role in cancer pathogenesis warrants further investigation.

Purpose of the Study:

• To elucidate the multifaceted roles of melatonin in cancer development.
• To explore the specific pathways through which melatonin affects tumor growth and metastasis.
• To assess the potential therapeutic applications of melatonin in oncology.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of molecular mechanisms involving melatonin signaling in cancer cells.
• Examination of epidemiological data linking melatonin levels to cancer incidence and progression.

Main Results:

• Melatonin demonstrates complex effects on cancer, acting as both an inhibitor and promoter depending on context.
• Key pathways affected include cell proliferation, apoptosis, angiogenesis, and immune modulation.
• Evidence suggests melatonin can influence metastasis through effects on cell adhesion and invasion.

Conclusions:

• Melatonin is a significant modulator of cancer progression, impacting tumor growth and metastasis.
• Understanding melatonin's diverse pathways is crucial for developing novel cancer therapies.
• Melatonin holds promise as a potential therapeutic agent in cancer treatment strategies.